Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has demonstrated average weight loss of 15% of body weight in clinical trials when dosed appropriately over time. Unlike some weight loss approaches, semaglutide requires a gradual dose escalation schedule that spans several weeks, allowing your body to adapt while reducing gastrointestinal side effects. Understanding how dosing works helps you set realistic expectations and commit to your personalized weight management plan.
How Semaglutide Dosing Works: The Titration Protocol
Semaglutide dosing follows a structured titration schedule that starts at the lowest effective dose and increases every four weeks. Your first injection is typically 0.25 milligrams, a dose chosen specifically because it activates GLP-1 receptors without overwhelming your system. This gradual approach gives your brain time to signal fullness and helps your digestive system adapt, which is why most patients tolerate the medication well when following the standard schedule.
The titration ladder progresses through predictable steps: week one through four at 0.25 mg, then 0.5 mg for the next month, followed by 1.0 mg, and finally reaching the therapeutic range of 1.7 to 2.4 mg weekly. Each step lasts approximately four weeks, meaning most patients reach their target dose around week 16 of treatment. This slow escalation is not arbitrary—it's based on clinical evidence showing that faster increases lead to more nausea and dropout rates, while gradual increases improve both safety and long-term adherence.
Finding Your Optimal Semaglutide Dose for Maximum Results
Your optimal semaglutide dose depends on several factors including your starting weight, metabolism, and how your GLP-1 receptors respond to the medication. The 2.4 mg weekly dose used in Novo Nordisk's STEP trials achieved the highest average weight loss, but many patients experience excellent results at lower maintenance doses like 1.7 mg or 2.0 mg. PlexusDx providers work with you to identify the minimum effective dose—the lowest amount that produces meaningful weight loss while keeping side effects manageable.
Some patients reach their weight loss goal at 1.0 mg or 1.7 mg and choose to stay at that dose rather than titrating further, which is a medically sound decision. The relationship between dose and weight loss is not perfectly linear; doubling your dose does not necessarily double your results. Your provider monitors your progress monthly and adjusts based on real outcomes, hunger reduction, and side effect tolerance rather than automatically pushing to maximum dose.
Semaglutide Dosing and Genetic Factors: Personalization Beyond One-Size-Fits-All
Genetic variations in your GLP-1 receptor (GLP1R rs6923761) and GIPR genes influence how strongly you respond to semaglutide at each dose level. Some patients have genetic predispositions that make them highly sensitive responders, meaning lower doses produce robust appetite suppression and weight loss. Others carry variants associated with reduced receptor sensitivity, potentially requiring higher doses to achieve the same clinical effect.
PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptide-related genes, including your specific GLP1R and GIPR variants, to predict your likely dose response. This genetic insight helps your provider personalize your titration schedule—patients with high-sensitivity variants may reach their goal at 1.0 mg, while those with lower-sensitivity patterns might benefit from progressing to 2.4 mg sooner. Testing costs $99 as an add-on after your first month of treatment and can transform your dosing strategy from guesswork into precision medicine.
Managing Side Effects While Titrating Your Semaglutide Dose
Nausea and reduced appetite are expected during dose escalation, but severity should decrease after three to five days at each new dose level as your body adapts. If nausea persists beyond one week or interferes with nutrition, your PlexusDx provider may recommend extending a single dose for an additional week before advancing, which is a valid clinical adjustment. Staying hydrated, eating smaller protein-rich meals, and taking anti-nausea medication as recommended by your provider significantly reduces side effect burden during titration.
Constipation commonly develops during semaglutide therapy and typically improves with increased fiber intake, hydration, and over-the-counter stool softeners rather than stopping the medication. Some patients experience reduced appetite so effectively that they forget to eat enough, leading to fatigue—your provider can help you establish minimum calorie targets during this period. Side effects are temporary signals that the medication is working, not reasons to abandon treatment; most patients find their sweet spot within four to eight weeks of starting.
PlexusDx Semaglutide Pricing: Your Dose Increases, Your Price Doesn't
PlexusDx offers compounded semaglutide injections starting at $149 per month with a flat-rate pricing model across all three commitment tiers. Your medication comes from licensed 503A compounding pharmacies regulated by state boards and the FDA, ensuring pharmaceutical-grade quality whether you choose the lowest or highest dose. The pricing guarantee means you titrate from 0.25 mg to 2.4 mg without ever seeing your monthly cost increase—PlexusDx's commitment is that dose escalation improves your results, not your bill.
Coverage includes all 50 states, requires no insurance, and incurs no membership fees, making semaglutide accessible to anyone committed to weight management. Payments are HSA and FSA eligible, providing significant tax advantages if you have these accounts. PlexusDx also offers oral semaglutide starting at $249 per month for patients who prefer tablets, plus genetic testing for $99 to unlock personalized dosing insights based on your unique peptide-pathway genetics.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once weekly, increased by 0.25 mg every four weeks until reaching the therapeutic range of 1.7 to 2.4 mg. This slow titration minimizes nausea and allows your GLP-1 receptors to adapt gradually. Most patients follow this schedule for 16 weeks before reaching their maintenance dose.
How much weight can you lose on semaglutide at different doses?
In STEP clinical trials, patients on 2.4 mg weekly lost an average of 15% of their body weight over 68 weeks, while those on 1.7 mg lost approximately 11%. Lower doses like 0.5 mg and 1.0 mg produced weight loss in the 3-7% range during early titration phases. Individual results vary based on genetics, lifestyle adherence, and metabolic factors.
Can I stay on a lower semaglutide dose if it's working for me?
Absolutely. Many patients achieve their weight loss goals at 1.0 mg or 1.7 mg and choose to maintain that dose indefinitely rather than titrating to 2.4 mg. Your PlexusDx provider supports whatever dose is effective and well-tolerated for you specifically, recognizing that more is not always better in weight management.
Does PlexusDx charge more for higher semaglutide doses?
No. PlexusDx semaglutide injections start at $149 per month with flat-rate pricing—your monthly cost remains the same whether you're taking 0.25 mg or 2.4 mg. This pricing model removes financial barriers to reaching your optimal therapeutic dose.
How can genetics help determine my ideal semaglutide dose?
PlexusDx's Precision Peptide Genetic Test ($99 add-on) identifies your GLP1R and GIPR variants, which predict whether you're a high-responder or low-responder to semaglutide. High-responders often reach goals at lower doses, while low-responders may benefit from higher doses—this genetic insight personalizes your titration schedule beyond standard protocols.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where Should You Inject Ozempic for Weight Loss?
Optimizing Your Ozempic® Schedule: What is the Best Time of Day to Take It?